These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 27887614)
1. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates. Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614 [TBL] [Abstract][Full Text] [Related]
2. No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo. Mayengue PI; Niama RF; Kouhounina Batsimba D; Malonga-Massanga A; Louzolo I; Loukabou Bongolo NC; Macosso L; Ibara Ottia R; Kimbassa Ngoma G; Dossou-Yovo LR; Pembet Singana B; Ahombo G; Sekangue Obili G; Kobawila SC; Parra HJ BMC Infect Dis; 2018 Oct; 18(1):538. PubMed ID: 30373565 [TBL] [Abstract][Full Text] [Related]
3. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal. Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy. Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053 [TBL] [Abstract][Full Text] [Related]
5. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B Malar J; 2014 Dec; 13():472. PubMed ID: 25471113 [TBL] [Abstract][Full Text] [Related]
7. Molecular assessment of artemisinin resistance markers, polymorphisms in the k13 propeller, and a multidrug-resistance gene in the eastern and western border areas of Myanmar. Nyunt MH; Hlaing T; Oo HW; Tin-Oo LL; Phway HP; Wang B; Zaw NN; Han SS; Tun T; San KK; Kyaw MP; Han ET Clin Infect Dis; 2015 Apr; 60(8):1208-15. PubMed ID: 25537878 [TBL] [Abstract][Full Text] [Related]
8. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa? Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646 [TBL] [Abstract][Full Text] [Related]
9. K13-propeller gene polymorphisms of Plasmodium falciparum and the therapeutic effect of artesunate among migrant workers returning to Guangxi, China (2014-2017). Li J; Shi Y; Zhang W; Yan H; Lin K; Wei S; Wei H; Yang Y; Huang S; Lu Y; Ma A; Qin J Malar J; 2019 Oct; 18(1):349. PubMed ID: 31619243 [TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962 [TBL] [Abstract][Full Text] [Related]
11. K13 Propeller Mutations in Plasmodium falciparum Populations in Regions of Malaria Endemicity in Vietnam from 2009 to 2016. Thuy-Nhien N; Tuyen NK; Tong NT; Vy NT; Thanh NV; Van HT; Huong-Thu P; Quang HH; Boni MF; Dolecek C; Farrar J; Thwaites GE; Miotto O; White NJ; Hien TT Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137815 [TBL] [Abstract][Full Text] [Related]
13. Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular Assays. Cooper RA; Conrad MD; Watson QD; Huezo SJ; Ninsiima H; Tumwebaze P; Nsobya SL; Rosenthal PJ Antimicrob Agents Chemother; 2015 Aug; 59(8):5061-4. PubMed ID: 26033725 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium berghei K13 Mutations Mediate Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP mBio; 2020 Nov; 11(6):. PubMed ID: 33173001 [TBL] [Abstract][Full Text] [Related]
15. Updates on k13 mutant alleles for artemisinin resistance in Plasmodium falciparum. Zaw MT; Emran NA; Lin Z J Microbiol Immunol Infect; 2018 Apr; 51(2):159-165. PubMed ID: 28711439 [TBL] [Abstract][Full Text] [Related]
16. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum. Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957 [TBL] [Abstract][Full Text] [Related]
17. Molecular Epidemiology of Malaria in Cameroon and Côte d'Ivoire. XXXI. Kelch 13 Propeller Sequences in Djaman JA; Olefongo D; Ako AB; Roman J; Ngane VF; Basco LK; Tahar R Am J Trop Med Hyg; 2017 Jul; 97(1):222-224. PubMed ID: 28719312 [TBL] [Abstract][Full Text] [Related]
18. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand. Putaporntip C; Kuamsab N; Kosuwin R; Tantiwattanasub W; Vejakama P; Sueblinvong T; Seethamchai S; Jongwutiwes S; Hughes AL Clin Microbiol Infect; 2016 Mar; 22(3):285.e1-8. PubMed ID: 26548510 [TBL] [Abstract][Full Text] [Related]
19. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children. Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB Malar J; 2016 Jan; 15():36. PubMed ID: 26801909 [TBL] [Abstract][Full Text] [Related]